Enhancing #pathology lab performance through a holistic approach to tissue staining. Our latest video showcases how patient case management supports labs in optimizing their workflow efficiency. Discover the full story here: https://bit.ly/4aksDiN #Immunohistochemistry #Pathology
Agilent Dako Pathology Solutions
Biotechnology Research
Santa Clara, California 5,269 followers
Agilent delivers trusted answers to our customers’ critical questions and challenges.
About us
Agilent is a global leader in life sciences, diagnostics, and applied chemical markets providing laboratories worldwide with instruments, services, consumables, applications, and expertise, enabling customers to gain the insights they seek. Agilent's expertise and trusted collaboration give them the highest confidence in our solutions. Our high-quality diagnostic antibodies, reagents, instruments, software, and expertise help pathology laboratories make accurate tissue-based cancer diagnoses and determine the most effective treatment for cancer patients. We are proud to be a renowned provider of complete pathology solutions, as highlighted by our Agilent Dako portfolio, and trusted by clinical laboratories around the world in the fight against cancer. By establishing lasting partnerships worldwide with partnering companies, ranging from large multinationals to smaller manufacturers and commercial laboratories, we support the fields of in vitro diagnostics, biotechnology, and pharmaceuticals. Agilent’s strong track record in developing, validating, and commercializing companion diagnostics, in partnership with pharmaceutical companies, positions us as a global leader in CDx and precision oncology.
- Website
-
http://www.agilent.com
External link for Agilent Dako Pathology Solutions
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Santa Clara, California
- Founded
- 1999
- Specialties
- Anatomic Pathology, Histology, Histopathology, Tissue Diagnostics, Staining Solutions, in-vitro, and Companion Diagnostics
Updates
-
Are you attending at Vårmötet i Patologi 2024 today? If so, be sure to come and visit us to speak to an Agilent Expert on booth #27 to see how our solutions can support you - we offer a broad #pathology and #genomics solutions portfolio that includes instruments, reagents, software, #digitalpathology offerings, and service and support. D0113305_1.00
-
Ready to gain a deeper understanding of the TPS scoring system and the heterogeneity of PD-L1 expression in tumors? Join Dr. Phillipe Taniere as he provides an in-depth explanation, complete with a case study from his clinic. Don’t miss this opportunity to learn directly from the expert. Watch the insight full video here: https://bit.ly/49XcccC #PDL1 #TPS #NSCLC D0110827_1.00
-
This month, the “Precision Pathology Insights” webinar series returns for its eighth season with veteran pathology trainer, Ed Manna, and special Q&A panelist and renowned pathologist, Dr. Ghislain Noumsi. Sign up to sharpen your command of PD-L1 testing: https://bit.ly/4aLhF6Y D0112681 1.00
-
Do you know about our AI-based image analysis? Our newly launched PD-L1 APP is indicated as an aid to the pathologist in the assessment of non-small cell lung cancer patients. Check out our PD-L1 APP flyer for more information: PD-L1 APP Come and speak to Agilent at booth #27 at Vårmötet i Patologi to learn more! https://bit.ly/3y3qTN8 #digitalpathology #pdl1 D0113304_1.00
-
Did you know that our HercepTest™ mAb pharmDx on Dako Omnis has shown a strong performance in NordiQC? Take a look at our brochure to discover more about our HercepTest™ mAb pharmDx on Dako Omnis: HercepTest™. Visit #Agilent at booth #27 to learn more! https://bit.ly/44wxf3M #HerceptTest #PharmDx #pathology D0113303_1.00
-
Learn the details of calculating CPS near the cut-off with Dr. David Hardisson! Join him as he delves into a detailed case study example, providing expert guidance every step of the way. To watch the full video, click here: https://bit.ly/3x5orW4 #pathology #TNBC #PDL1 #CPS D0110825_1.00
-
Are you curious about which tumor cells to include when calculating TPS for NSCLC? Join Dr. Phillipe Taniere as he elucidates the process and walks you through a case study example. Gain first-hand knowledge and sharpen your skills by watching the full video here: https://bit.ly/3PAoOOH #PDL1 #TPS #NSCLC D0110826_1.00
-
Join #Agilent and special guest presenter Dr. Emina Torlakovic for the April A la Carte Webinar. Dr. Torlakovic will explore the clinical utility of different tools for the assessment of IHC LoD (limit of detection), why measuring LoD is clinically relevant, and where it fits in the workflow of clinical IHC laboratories. 🔬 Don't miss this opportunity to earn CEU credit. 💻 Can’t attend? The webinar will be available on-demand until April 26. ✅ https://bit.ly/49Z3kmY
-
Include the new p16 antibody for Agilent Dako Omnis in your menu for #cervical #cancer classification. Based on the trusted p16 clone JC8, this antibody is provided in FLEX ready-to-use format for Dako Omnis and is validated for use in classification of cervical nondysplastic, dysplastic, and neoplastic lesions. Visit the product page to see IHC stains and learn more: https://bit.ly/3VFGQ65 D0112101